International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost JTH, vol.4, issue.2, pp.295-306, 2006. ,
,
, Ann Med Interne, vol.154, issue.1, pp.51-59, 2003.
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis, Autoimmun Rev, 2017. ,
Antiphospholipid syndrome, Thromb Res, vol.151, issue.1, pp.43-50, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02346750
,
, Syndrome des antiphospholipides. Classification actuelle et indications thérapeutiques
, , vol.13, pp.111-132, 2007.
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry, J Autoimmun, vol.32, issue.3-4, pp.240-245, 2009. ,
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry, Autoimmun Rev, vol.15, issue.12, pp.1120-1124, 2016. ,
Revisiting Libman-Sacks endocarditis: a historical review and update, Clin Rev Allergy Immunol, vol.36, issue.23, pp.126-156, 2009. ,
The cardiac manifestations of antiphospholipid syndrome and their echocardiographic recognition, J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr, vol.22, issue.10, pp.1100-1108, 2009. ,
Valvular heart disease in antiphospholipid syndrome, Curr Rheumatol Rep, vol.15, issue.4, p.320, 2013. ,
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution, Am J Med, vol.120, issue.7, pp.636-678, 2007. ,
Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation, vol.124, pp.215-239, 2011. ,
Two and three-dimensional echocardiography in primary antiphospholipid syndrome: misdiagnosis as rheumatic valve disease, Lupus, vol.10, issue.7, pp.511-514, 2001. ,
Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study, Stroke, vol.36, issue.3, pp.592-598, 2005. ,
Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography, Lupus, vol.9, issue.6, pp.406-418, 2000. ,
,
Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study, J Rheumatol, vol.31, issue.12, pp.2402-2409, 2004. ,
Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study, Int J Rheum Dis, vol.18, issue.1, pp.76-83, 2015. ,
Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, followup study, Arthritis Care Res, vol.53, issue.3, pp.460-467, 2005. ,
Leftsided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus, Lupus, vol.12, issue.11, pp.805-817, 2003. ,
,
Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome, Ann Rheum Dis, vol.60, issue.1, pp.43-51, 2001. ,
Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus, Cardiology, vol.108, issue.4, pp.331-338, 2007. ,
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment, Committee consensus report. Lupus, vol.12, issue.7, pp.518-541, 2003. ,
,
, Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions, Lupus, vol.20, issue.2, pp.165-73, 2011.
Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases, Eur J Cardiothorac Surg, vol.37, issue.1, pp.154-162, 2010. ,
The antiphospholipid syndrome and heart valve surgery. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg, vol.33, pp.168-81, 2008. ,
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe, Lupus, 2009. ,
Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome, Ann Rheum Dis, vol.66, issue.4, pp.506-516, 2007. ,
,
, Diastolic dysfunction is a feature of the antiphospholipid syndrome, Am Heart J, 1995.
M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome, Br Heart J, vol.74, issue.5, pp.531-536, 1995. ,
The lung in the antiphospholipid syndrome, Ann Rheum Dis, vol.61, issue.3, pp.195-203, 2002. ,
Pulmonary hypertension in antiphospholipid syndrome, Curr Rheumatol Rep, vol.17, issue.1, p.478, 2015. ,
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis Rheum, vol.46, issue.4, pp.1019-1046, 2002. ,
Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study, Stroke, vol.36, issue.3, pp.592-598, 2005. ,
,
,
, Lupus, vol.9, issue.4, pp.236-276, 2000.
Cardiac valve replacement in patients with antiphospholipid syndrome, Arthritis Care Res, vol.64, issue.8, pp.1256-60, 2012. ,
DOI : 10.1002/acr.21670
URL : https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/acr.21670
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome, Arthritis Rheum, vol.65, issue.2, pp.464-71, 2013. ,
Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review ,
, Med Clin (Barc), vol.144, pp.97-104, 2015.
,
, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 2008.
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 1997. ,
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study, Thromb Res, vol.132, issue.1, pp.1-7, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01709884
New ASE Guidelines for Evaluating Valve Regurgitation-An Integrative Approach | American Society of Echocardiography, 2018. ,
, Recommendations for the echocardiographic assessment of native valvular regurgitation:-eacvi-recommendations-valvular-regurgitation-summary
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus, Eur J Rheumatol, vol.3, issue.2, pp.75-84, 2016. ,
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment, Committee consensus report. Lupus, vol.12, issue.7, pp.518-541, 2003. ,
LibmanSacks endocarditis associated with antiphospholipid syndrome and infection, Thromb Res, vol.114, issue.5-6, pp.589-92, 2004. ,
DOI : 10.1016/j.thromres.2004.06.039
The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis, Eur J Clin Invest, vol.47, issue.5, pp.366-71, 2017. ,
Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus, Autoimmun Rev, vol.15, issue.12, pp.1134-1174, 2016. ,
Aortic stenosis, aortic regurgitation and arterial hypertension, Curr Vasc Pharmacol ,
DOI : 10.2174/1570161116666180101165306
Arterial hypertension and aortic valve stenosis: Shedding light on a common "liaison, Hellenic J Cardiol, vol.58, issue.4, pp.261-267, 2017. ,
DOI : 10.1016/j.hjc.2017.03.005
URL : https://doi.org/10.1016/j.hjc.2017.03.005
Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome, Clin Exp Rheumatol, vol.31, issue.5, pp.756-60, 2013. ,
Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis, Lupus, vol.16, issue.3, pp.176-80, 2007. ,
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies, Lupus, vol.12, issue.7, pp.514-521, 2003. ,
Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders, Am J Med, 2018. ,
Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome, Isr Med Assoc J IMAJ, vol.16, issue.3, pp.162-169, 2014. ,
An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus, N Engl J Med, vol.335, pp.1424-1454, 1996. ,
IgA Antiphospholipid Antibodies and Anti-Domain ,
, of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid Syndrome, Adv Clin Exp Med Off Organ Wroclaw Med Univ, vol.23, issue.5, pp.729-762, 2014.
,
, Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics, J Am Coll Cardiol, vol.69, issue.18, pp.2317-2347, 2009.
Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome, N Engl J Med, 2014. ,
, Jul, vol.24, issue.4, pp.303-315
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost JTH, vol.4, issue.2, pp.295-306, 2006. ,
,
, Ann Med Interne, vol.154, issue.1, pp.51-59, 2003.
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis, Autoimmun Rev, 2017. ,
Antiphospholipid syndrome, Thromb Res, vol.151, issue.1, pp.43-50, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01936357
,
, Syndrome des antiphospholipides. Classification actuelle et indications thérapeutiques
, , vol.13, pp.111-132, 2007.
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry, J Autoimmun, vol.32, issue.3-4, pp.240-245, 2009. ,
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry, Autoimmun Rev, vol.15, issue.12, pp.1120-1124, 2016. ,
Revisiting Libman-Sacks endocarditis: a historical review and update, Clin Rev Allergy Immunol, vol.36, issue.23, pp.126-156, 2009. ,
The cardiac manifestations of antiphospholipid syndrome and their echocardiographic recognition, J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr, vol.22, issue.10, pp.1100-1108, 2009. ,
Valvular heart disease in antiphospholipid syndrome, Curr Rheumatol Rep, vol.15, issue.4, p.320, 2013. ,
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution, Am J Med, vol.120, issue.7, pp.636-678, 2007. ,
Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation, vol.124, pp.215-239, 2011. ,
Two and three-dimensional echocardiography in primary antiphospholipid syndrome: misdiagnosis as rheumatic valve disease, Lupus, vol.10, issue.7, pp.511-514, 2001. ,
Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study, Stroke, vol.36, issue.3, pp.592-598, 2005. ,
Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography, Lupus, vol.9, issue.6, pp.406-418, 2000. ,
Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome, Am J Cardiol, vol.96, issue.4, pp.574-583, 2005. ,
Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study, J Rheumatol, vol.31, issue.12, pp.2402-2409, 2004. ,
Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study, Int J Rheum Dis, vol.18, issue.1, pp.76-83, 2015. ,
Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, followup study, Arthritis Care Res, vol.53, issue.3, pp.460-467, 2005. ,
Leftsided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus, Lupus, vol.12, issue.11, pp.805-817, 2003. ,
,
Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome, Ann Rheum Dis, vol.60, issue.1, pp.43-51, 2001. ,
Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus, Cardiology, vol.108, issue.4, pp.331-338, 2007. ,
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment, Committee consensus report. Lupus, vol.12, issue.7, pp.518-541, 2003. ,
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions, Lupus, vol.20, issue.2, pp.165-73, 2011. ,
Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases, Eur J Cardiothorac Surg, vol.37, issue.1, pp.154-162, 2010. ,
The antiphospholipid syndrome and heart valve surgery. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg, vol.33, pp.168-81, 2008. ,
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe, Lupus, 2009. ,
Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome, Ann Rheum Dis, vol.66, issue.4, pp.506-516, 2007. ,
Diastolic dysfunction is a feature of the antiphospholipid syndrome, Am Heart J, 1995. ,
M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome, Br Heart J, vol.74, issue.5, pp.531-536, 1995. ,
The lung in the antiphospholipid syndrome, Ann Rheum Dis, vol.61, issue.3, pp.195-203, 2002. ,
Pulmonary hypertension in antiphospholipid syndrome, Curr Rheumatol Rep, vol.17, issue.1, p.478, 2015. ,
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis Rheum, vol.46, issue.4, pp.1019-1046, 2002. ,
Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study, Stroke, vol.36, issue.3, pp.592-598, 2005. ,
Left ventricular thrombus mimicking primary cardiac tumor in a patient with primary antiphospholipid syndrome and recurrent systemic embolism, Cardiol J, vol.16, issue.6, pp.560-563, 2009. ,
Cardiac abnormalities in SLE: pancarditis, Lupus, vol.9, issue.4, pp.236-276, 2000. ,
Cardiac valve replacement in patients with antiphospholipid syndrome, Arthritis Care Res, vol.64, issue.8, pp.1256-60, 2012. ,
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome, Arthritis Rheum, vol.65, issue.2, pp.464-71, 2013. ,
Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review ,
, Med Clin (Barc), vol.144, pp.97-104, 2015.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 2008. ,
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 1997. ,
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study, Thromb Res, vol.132, issue.1, pp.1-7, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01709884
New ASE Guidelines for Evaluating Valve Regurgitation-An Integrative Approach | American Society of Echocardiography, 2018. ,
, Recommendations for the echocardiographic assessment of native valvular regurgitation:-eacvi-recommendations-valvular-regurgitation-summary
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus, Eur J Rheumatol, vol.3, issue.2, pp.75-84, 2016. ,
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment, Committee consensus report. Lupus, vol.12, issue.7, pp.518-541, 2003. ,
LibmanSacks endocarditis associated with antiphospholipid syndrome and infection, Thromb Res, vol.114, issue.5-6, pp.589-92, 2004. ,
DOI : 10.1016/j.thromres.2004.06.039
The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis, Eur J Clin Invest, vol.47, issue.5, pp.366-71, 2017. ,
DOI : 10.1111/eci.12744
Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus, Autoimmun Rev, vol.15, issue.12, pp.1134-1174, 2016. ,
Aortic stenosis, aortic regurgitation and arterial hypertension, Curr Vasc Pharmacol ,
DOI : 10.2174/1570161116666180101165306
Arterial hypertension and aortic valve stenosis: Shedding light on a common "liaison, Hellenic J Cardiol, vol.58, issue.4, pp.261-267, 2017. ,
DOI : 10.1016/j.hjc.2017.03.005
URL : https://doi.org/10.1016/j.hjc.2017.03.005
Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome, Clin Exp Rheumatol, vol.31, issue.5, pp.756-60, 2013. ,
Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis, Lupus, vol.16, issue.3, pp.176-80, 2007. ,
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies, Lupus, vol.12, issue.7, pp.514-521, 2003. ,
Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders, Am J Med, 2018. ,
Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome, Isr Med Assoc J IMAJ, vol.16, issue.3, pp.162-169, 2014. ,
An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus, N Engl J Med, vol.335, pp.1424-1454, 1996. ,
IgA Antiphospholipid Antibodies and Anti-Domain 1 of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid Syndrome, Adv Clin Exp Med Off Organ Wroclaw Med Univ, vol.23, issue.5, pp.729-762, 2014. ,
Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics, J Am Coll Cardiol, vol.69, issue.18, pp.2317-2347, 2009. ,
Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome, N Engl J Med, 2014. ,
, Jul, vol.24, issue.4, pp.303-315